Cellectis S.A. (CLLS) Return on equity 2016–2025
Cellectis S.A. (CLLS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-89.1%FY2025 · since FY2016: -24.7% → -89.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -89.1% | -61.0 pp |
| FY2024 | -28.1% | +91.3 pp |
| FY2023 | -119.3% | -29.3 pp |
| FY2022 | -90.0% | -38.4 pp |
| FY2021 | -51.6% | -23.0 pp |
| FY2020 | -28.6% | +3.8 pp |
| FY2019 | -32.4% | -13.2 pp |
| FY2018 | -19.2% | +18.3 pp |
| FY2017 | -37.5% | -12.9 pp |
| FY2016 | -24.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CLLS financial trends
CLLS RevenueCLLS Net incomeCLLS Net marginCLLS Gross profitCLLS Gross marginCLLS Operating incomeCLLS Operating marginCLLS Operating cash flowCLLS Free cash flowCLLS Capital expendituresCLLS Stock buybacksCLLS Dividends paidCLLS Total assetsCLLS Total liabilitiesCLLS Shareholders’ equityCLLS overview →